Is Development of a Vaccine against Cryptococcus neoformans Feasible?

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

Chrissy M. Leopold Wager,

Affiliations Department of Biology, The University of Texas at San Antonio, San Antonio, Texas, United States of America, The South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, United States of America
⨯
Floyd L. Wormley Jr.

* E-mail: floyd.wormley@utsa.edu

Affiliations Department of Biology, The University of Texas at San Antonio, San Antonio, Texas, United States of America, The South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, United States of America
⨯

Reader Comments (0)

Cryptococcus neoformans
Is the Subject Area "Cryptococcus neoformans" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Cryptococcosis
Is the Subject Area "Cryptococcosis" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Cell-mediated immunity
Is the Subject Area "Cell-mediated immunity" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.